The data presented in this figure suggest that the expression of DNMT-1, PD1, Dicer1, and PD-L1 is markedly higher in prostate cancer patients compared to normal individuals and that their expression levels are positively correlated with the Gleason score. Here, DNMT1 is linked to prostate carcinoma.